ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$1.58
+0.02 (+1.28%)
Open$1.55
Previous Close$1.56
Day High$1.61
Day Low$1.52
52W High$13.25
52W Low$1.17
Volume—
Avg Volume63.6K
Market Cap6.87M
P/E Ratio—
EPS$-11.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+527.2% upside
Current
$1.58
$1.58
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 16.93B | 16.38B | 1.01M |
| Net Income | -111,187,917 | -96,825,471 | 237.2K |
| Profit Margin | -14.0% | -13.3% | 23.5% |
| EBITDA | -108,673,271 | -99,893,185 | 375.3K |
| Free Cash Flow | — | — | 127.9K |
| Rev Growth | +3.4% | +3.4% | -4.2% |
| Debt/Equity | — | — | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |